TVTX
Travere Therapeutics Inc
52.10$
+0.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 1.13 | 2.66 | 3.49 | 4.00 | 4.06 | 4.14 | 4.17 | 2.20 | 1.72 | 1.96 | 2.96 | 5.50 | |
| – | – | – | – | 0.02 | 0.06 | 0.12 | 0.09 | 0.14 | 0.12 | 0.13 | 0.06 | 0.07 | 0.15 | 0.10 | 0.12 | |
| – | – | – | – | 1.10 | 2.60 | 3.37 | 3.90 | 3.93 | 4.02 | 4.04 | 2.14 | 1.65 | 1.80 | 2.86 | 5.38 | |
| – | – | 0.06 | 0.50 | 1.91 | 1.34 | 1.85 | 2.02 | 3.06 | 3.33 | 2.77 | 3.36 | 3.57 | 3.30 | 3.58 | 2.31 | |
| 0.00 | 0.00 | 2.84 | 1.19 | 2.38 | 2.12 | 2.56 | 2.68 | 2.56 | 3.05 | 2.86 | 2.11 | 3.10 | 3.58 | 3.35 | 3.78 | |
| 0.00 | 0.00 | 2.84 | 1.69 | 4.29 | 3.46 | 4.41 | 4.70 | 5.62 | 6.37 | 7.75 | 5.47 | 6.66 | 7.03 | 6.96 | 6.09 | |
| 0.00 | 0.00 | -2.83 | -1.69 | -3.18 | -1.35 | -1.52 | -1.39 | -1.98 | -2.36 | -3.71 | -3.33 | -5.02 | -5.23 | -4.10 | -0.70 | |
| 0.00 | 0.00 | 0.01 | 1.37 | 2.20 | 0.52 | 0.12 | 0.11 | 0.24 | 0.44 | 0.40 | 0.33 | 0.17 | 0.15 | 0.14 | 0.12 | |
| 0.00 | 0.00 | -2.84 | -2.38 | -4.53 | 2.81 | -1.50 | -1.51 | -2.52 | -3.46 | -3.97 | -3.62 | -5.19 | -5.06 | -4.06 | -0.55 | |
| 0.00 | – | 0.00 | 0.01 | -0.10 | -0.31 | -0.25 | 0.04 | 0.02 | 0.00 | -0.41 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | |
| 0.00 | 0.00 | -2.84 | -2.38 | -4.43 | 3.12 | -1.25 | -1.54 | -2.54 | -3.46 | -3.56 | -3.01 | -4.37 | -1.50 | -4.08 | -0.29 | |
| 0.00 | 0.00 | -2.82 | -0.99 | -2.96 | 3.44 | -1.01 | -1.00 | -1.82 | -2.53 | -3.05 | -3.08 | -4.70 | -4.39 | -3.37 | 0.25 |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.